Post-approval studies (Phase 4)UnknownNCT03368274
What this trial is testing
To Evaluate the Clinical Efficacy of Iguratimod in the Treatment of IgG4 Related Disease (IgG4-RD) With Mild Symptom
Who this might be right for
IgG4-related Disease
Wen Zhang 30